NLRP3 and Hyperglycemia: In the state of hyperglycemia, abnormal expression of MIOX activates NLRP3 inflammasomes, leading to increased release of inflammatory mediators, promoting inflammatory response, leading to pancreatic cell damage, and exacerbating insulin resistance.